Overview
MSA Capital is a global investment firm founded in 2014, managing over USD 2 billion in private venture and growth assets. The firm focuses on highly innovative and disruptive companies in biotechnology and enterprise-facing core technology, with a significant emphasis on the healthcare and longevity sectors.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.